Clarity Pharmaceuticals Ltd has released a press release.
Clarity launches $121 million equity raise
Filed with ASX ·
6ix hasn’t read this filing yet.
Clarity Pharmaceuticals Ltd. on 6ix
In the deck
Earlier from Clarity Pharmaceuticals
- Trading Halt
- First participant treated in the last dose escalation cohort
- Theranostic prostate cancer trial advances to multi-dose
- Additional COBRA trial data results
- S&P DJI Announces March 2024 Quarterly Rebalance
Later from Clarity Pharmaceuticals
- Investor Presentation
- Completion of Placement and Institutional Entitlement Offer
- Despatch of Retail Entitlement Offer Booklet
- Successful Completion of Retail Entitlement Offer
- Complete response with Cu-67 SAR-bisPSMA
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals